[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-322859-105":59,"doc-detail-322859-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","clinical-staging-system-for-carcinoma-of-the-uterus-preface-tnm-system","CLINICAL STAGING SYSTEM FOR CARCINOMA OF THE UTERUS - Preface & TNM System","","Clinical staging systems for carcinoma of the uterus are presented for the cervix and corpus uteri, including a revision to the previously published 1964 approach. The document outlines how changes improve definitions of TNM categories, refine T1 subdivision for corpus cancer, and adjust regional node metastasis and cervix-specific N2 classification for fixed pelvic wall masses. It further explains the TNM framework for primary tumor, regional lymph nodes, and distant metastasis, and describes how stage groupings are derived. The AJCC is introduced with its organization and field-trial development process.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/clinical-staging-system-for-carcinoma-of-the-uterus-preface-tnm-system/322859/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/clinical-staging-system-for-carcinoma-of-the-uterus-preface-tnm-system/322859.png","ImageObject",300,407,{"name":92,"@type":93},"Sage","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the clinical staging system intended to do for uterine cancer?","Question",{"text":113,"@type":114},"It categorizes the primary tumor and the extent of involvement for assessment of malignant disease, with specific criteria modified by anatomic site.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does the document define T, N, and M in the TNM system?",{"text":118,"@type":114},"T describes the primary tumor (including TIS for carcinoma in situ and TX when it cannot be assessed), N describes regional lymph nodes (including categories for demonstrable nodes and suspected metastasis), and M describes distant metastasis (including M0 for no evidence and M1/M2/M3 for increasing involvement).",{"name":120,"@type":111,"acceptedAnswer":121},"What major changes were made in the revised staging method compared with the 1964 version?",{"text":122,"@type":114},"The revision introduces more specific definitions of TNM categories, splits T1 into T1a and T1b for corpus cancer, expands regional node metastasis definitions for the corpus, and adds an N2 category for cervix cancers to account for a palpable fixed mass on the pelvic wall.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},322859,1790194164,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":31,"preview_page_count":4},687197207057,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","星ClinicalCarcinoma of the VterusCERVIxand cORUs(Revision)  \n爱  \nJuly 1972  \n# CLINICAL STAGING SYSTEM FOR CARCINOMA\n\nOF THE UTERUS  \nTABLE OF CONTENTS  \n…………………………………2  \nPreface………………………………………………  \n…………………………………3  \nThe TNM System ……………  \nAmerican Joint Committee for Cancer Staging  \n……………………………………4  \nand End Results Reporting  \n…………………………………5  \nGeneral Rules for Staging ………………………  \nSpecific Considerations in Classifying Carcinoma of the Uterus……7  \nDefinition of TNM Categories and Stage Grouping  \n………………………………………8  \nas Applied to Carcinoma of the Cervix.  \n…………………………………………………10  \nStage Grouping ……………  \nDefinition of TNM Categories and Stage Groupings  \nas Applied to Carcinoma of the Corpus Uteri………………………11  \nTask Force on Revision of Staging of Carcinoma of the Uterus..13  \nAmerican Joint Committee for Cancer Staging and End  \nResults Reporting—Membership, January,1972 …………………14  \nPublications of the American Joint Committee for  \nCancer Staging and End Results Reporting ……………………………15  \nThis project was supported in part by funds from the National  \nCancer Institute(grant series CA 11606)and the American  \nCancer Society(grant series MG-99).  \n八8  \nA512   \n n0.415   \n1972  \nPR EFA CE  \nThe clinical staging systems suggested by the American JointCommittee for cervix and corpus uteri were published in 1964.Extensive reviews using these staging methods demonstrated theeffectiveness of the systems in predicting survival.  \nThe American Joint Committee and the TNM Committee of theUICC jointly restudied the staging methods.A uniform method ofstage classification of uterine cancer was agreed upon and acceptedby both groups.  \nThe revised staging method is similar to that published in 1964.The significant changes are:  \n1.More specific definitions of the original TNM categories.  \n2.For corpus cancer,T1 is divided into two groups,Tla and TIb,to document uterine enlargement.  \n3.  Regional node metastasis for carcinoma of the corpus are de-fined as including intra-abdominal para-aortic nodes proximalto the bifurcation of the common iliac arteries.  \n4.  For cervix cancers,an N2 category is added to provide for thepalpable fixed mass on the pelvic wall.  \n# THE TNM SYSTEM\n\nThe TNM system provides for the categorization of the primarylesion and the extent of involvement in assessment of malignantdisease.Specific criteria modify this system according to the ana-tomic site.  \nThree capital letters are used:T-PRIMARY TUMOR  \n# N-REGIONAL LYMPH NODES\n\nM-DISTANT METASTASIS  \nThis classification is extended by the following designations:  \nTUMOR:TO —No evidence of primary tumorTIS —Carcinoma in situ  \nT1,T2,T3,T4—Ascending degrees of increase intumor size and involvementTX —Tumor cannot be assessed  \nNODES:NO—Regional lymph nodes not demonstrableN1a,N2a—Demonstrable regional lymph nodes,metastasis not suspected  \nN1b,N2b,N3—Demonstrable regional lymph nodes,metastasis suspected  \nNX—Regional lymph nodes cannot beassessed clinically  \nMETASTASIS:MO—No evidence of distant metastasis  \nM1,M2,M3—Ascending degrees of metastaticinvolvement of the host,including distant nodes  \nTNM assignments may be grouped into a small number ofstages.Stage grouping for each site is recommended on the basisof the specific field trials.  \n# AMERICAN JOINT COMMITTEE FOR CANCER STAGINGAND END RESULTS REPORTING\n\nThe American Joint Committee for Cancer Staging and EndResults Reporting(AJCCS)was organized on January 9,1959,withthe purpose of developing a system of clinical staging of cancer bysite acceptable to the American medical profession.The sponsoringorganizations are:the American College of Surgeons,the AmericanCollege of Radiology,the College of American Pathologists,theAmerican College of Physicians,the American Cancer Society,Inc.,and the National Cancer Institute.Each of the sponsoring organiza-tions designates members of the Committee.The American Collegeof Surgeons serves as administrative sponsor.Subcommittees,desig-nated as “task forces”have been appointed","cbCaieK12lESicGS","https://ap.wps.com/l/cbCaieK12lESicGS","pdf",606322,"English","# CLINICAL STAGING SYSTEM FOR CARCINOMA OF THE UTERUS\n## TABLE OF CONTENTS\n## Preface\n## The TNM System\n## General Rules for Staging\n## Specific Considerations in Classifying Carcinoma of the Uterus\n## Definition of TNM Categories and Stage Grouping as Applied to the Cervix\n## Stage Grouping for the Cervix\n## Definition of TNM Categories and Stage Groupings as Applied to the Corpus Uteri\n## Task Force on Revision of Staging of Carcinoma of the Uterus\n## American Joint Committee for Cancer Staging and End Results Reporting—Membership, January 1972\n## Publications of the American Joint Committee for Cancer Staging and End Results Reporting\n## THE TNM SYSTEM\n## AMERICAN JOINT COMMITTEE FOR CANCER STAGING AND END RESULTS REPORTING","[{\"question\":\"What is the clinical staging system intended to do for uterine cancer?\",\"answer\":\"It categorizes the primary tumor and the extent of involvement for assessment of malignant disease, with specific criteria modified by anatomic site.\"},{\"question\":\"How does the document define T, N, and M in the TNM system?\",\"answer\":\"T describes the primary tumor (including TIS for carcinoma in situ and TX when it cannot be assessed), N describes regional lymph nodes (including categories for demonstrable nodes and suspected metastasis), and M describes distant metastasis (including M0 for no evidence and M1/M2/M3 for increasing involvement).\"},{\"question\":\"What major changes were made in the revised staging method compared with the 1964 version?\",\"answer\":\"The revision introduces more specific definitions of TNM categories, splits T1 into T1a and T1b for corpus cancer, expands regional node metastasis definitions for the corpus, and adds an N2 category for cervix cancers to account for a palpable fixed mass on the pelvic wall.\"}]","CLINICAL STAGING SYSTEM FOR CARCINOMA OF THE UTERUS - Preface & TNM System | PDF",1789963744]